Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions. Export

@article{citeulike:5443354, abstract = {This review briefly summarizes the information on the molecular mechanisms of action, pharmacokinetic profiles and drug interactions of novel (third-generation) antiepileptic drugs, including brivaracetam, carabersat, carisbamate, DP-valproic acid, eslicarbazepine, fluorofelbamate, fosphenytoin, ganaxolone, lacosamide, losigamone, pregabalin, remacemide, retigabine, rufinamide, safinamide, seletracetam, soretolide, stiripentol, talampanel, and valrocemide. These novel antiepileptic drugs undergo intensive clinical investigations to assess their efficacy and usefulness in the treatment of patients with refractory epilepsy.}, author = {Luszczki, Jarogniew J.}, citeulike-article-id = {5443354}, citeulike-linkout-0 = {http://view.ncbi.nlm.nih.gov/pubmed/19443931}, citeulike-linkout-1 = {http://www.hubmed.org/display.cgi?uids=19443931}, issn = {1734-1140}, journal = {Pharmacological reports : PR}, keywords = {antiepileptic, drug, epilepsy, psychosis}, number = {2}, pages = {197--216}, posted-at = {2009-08-15 17:52:17}, priority = {2}, title = {Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions.}, url = {http://view.ncbi.nlm.nih.gov/pubmed/19443931}, volume = {61}, year = {2009} }

TY - JOUR ID - citeulike:5443354 L3 - citeulike-article-id:5443354 N2 - This review briefly summarizes the information on the molecular mechanisms of action, pharmacokinetic profiles and drug interactions of novel (third-generation) antiepileptic drugs, including brivaracetam, carabersat, carisbamate, DP-valproic acid, eslicarbazepine, fluorofelbamate, fosphenytoin, ganaxolone, lacosamide, losigamone, pregabalin, remacemide, retigabine, rufinamide, safinamide, seletracetam, soretolide, stiripentol, talampanel, and valrocemide. These novel antiepileptic drugs undergo intensive clinical investigations to assess their efficacy and usefulness in the treatment of patients with refractory epilepsy. IS - 2 JF - Pharmacological reports : PR SN - 1734-1140 EP - 216 TI - Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions. VL - 61 SP - 197 KW - antiepileptic KW - drug KW - epilepsy KW - psychosis AU - Luszczki, Jarogniew PY - 2009///r UR - http://view.ncbi.nlm.nih.gov/pubmed/19443931 ER -